Grants and Contributions:

Back to search

Title:

Canadian AI solutions for health technologies co-innovation mission to Japan

Agreement Number:

1023568

Agreement Value:

$5,000.00

Agreement Date:

Oct 13, 2024 - Dec 12, 2024

Description:

Participation in the Canadian AI solutions for health technologies (aging tech) co-innovation mission to Japan - December 2-6, 2024. A delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to explore the Japanese market and to develop international partnerships and potential project ideas under the Japan Program. In Partnership with the Trade Commissioner Service Canadian Technology Accelerator (TCS CTA), the Canadian delegation will also receive coaching and mentoring from industry leaders, support for their international business and market-entry strategies, as well as introductions to other potential partners and clients during the mission.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Toronto, Ontario, CA M5C 1K9

Reference Number:

172-2024-2025-Q3-1023568

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

784783318

Recipient Type:

For-profit organization

Recipient's Operating Name:

Lucid Therapeutics

Recipient's Legal Name:

Lucid, inc.

Federal Riding Name:

Toronto Centre

Federal Riding Number:

35108

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

51121